Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1994 Nov;49(11):1103–1108. doi: 10.1136/thx.49.11.1103

Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.

D R Baldwin 1, Z Sivardeen 1, I D Pavord 1, A J Knox 1
PMCID: PMC475270  PMID: 7831625

Abstract

BACKGROUND--The effect of adrenergic agonists in asthma depends on their net effect on microvascular leakage, mucosal oedema, vascular clearance of spasmogens, inhibition of cholinergic neurotransmission, and airway smooth muscle contractility. It has been postulated that adrenaline, by virtue of its alpha effects on the vasculature and cholinergic neurotransmission, may have additional useful properties in asthma compared with selective beta agonists such as salbutamol. METHODS--The airway effects of adrenaline (a non-selective adrenoreceptor agonist) were compared with the selective beta 2 agonist salbutamol. Their airway smooth muscle relaxant potencies and effect on histamine contraction in human bronchi in vitro were compared with their effects on airway calibre and histamine reactivity in asthmatic subjects in vivo. For the in vitro studies changes in tension were measured in response to these agents in thoracotomy specimens of human airways. In vivo the effects of adrenaline and salbutamol on airway calibre and histamine reactivity were measured in eight subjects with mild to moderate asthma in a randomised crossover study. RESULTS--Salbutamol and adrenaline had approximately equivalent airway smooth muscle relaxant potencies in vitro and bronchodilator potency in vivo. However, their effects on histamine induced contraction in vitro were significantly different from their effects on histamine reactivity in vivo. Salbutamol was less potent in vitro producing a mean (SE) 2.4 (0.15) doubling dose increase in the histamine EC20 and adrenaline a 5.2 (0.18) doubling dose increase (mean difference between salbutamol and adrenaline 2.8 doubling doses; 95% CI 1.1 to 4.5). Salbutamol had no effect on the maximal response to histamine whereas adrenaline reduced it by 54%. In contrast, salbutamol was more potent in vivo producing a mean (SE) increase in PD20 histamine of 1.84 (0.5) doubling doses whereas adrenaline was without effect increasing PD20 by only 0.06 (0.47) doubling doses (mean difference between adrenaline and salbutamol 1.78, 95% CI 0.26 to 3.29 doubling doses). CONCLUSIONS--These findings suggest that the alpha adrenergic airway effects of non-selective adrenoreceptor agonists such as adrenaline offer no additional protection against histamine-induced broncho-constriction in vivo than beta 2 selective drugs such as salbutamol, despite adrenaline providing greater protection against histamine-induced contraction in vitro. The differences between the effects of these agents in vitro and in vivo may be related to their opposing vascular effects in vivo.

Full text

PDF
1103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Naline E., Matran R., Toty L., Bakdach H. Interaction between fenoterol, ipratropium, and acetylcholine on human isolated bronchus. J Allergy Clin Immunol. 1988 Jul;82(1):40–46. doi: 10.1016/0091-6749(88)90049-8. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol. 1989 Jun;83(6):1013–1026. doi: 10.1016/0091-6749(89)90441-7. [DOI] [PubMed] [Google Scholar]
  3. Boschetto P., Roberts N. M., Rogers D. F., Barnes P. J. Effect of antiasthma drugs on microvascular leakage in guinea pig airways. Am Rev Respir Dis. 1989 Feb;139(2):416–421. doi: 10.1164/ajrccm/139.2.416. [DOI] [PubMed] [Google Scholar]
  4. Britton J., Hanley S. P., Garrett H. V., Hadfield J. W., Tattersfield A. E. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax. 1988 Apr;43(4):300–305. doi: 10.1136/thx.43.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carstairs J. R., Nimmo A. J., Barnes P. J. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis. 1985 Sep;132(3):541–547. doi: 10.1164/arrd.1985.132.3.541. [DOI] [PubMed] [Google Scholar]
  6. Casterline C. L., Evans R., 3rd, Ward G. W., Jr The effect of atropine and albuterol aerosols on the human bronchial response to histamine. J Allergy Clin Immunol. 1976 Nov;58(5):607–613. doi: 10.1016/0091-6749(76)90207-4. [DOI] [PubMed] [Google Scholar]
  7. Chung K. F., Morgan B., Keyes S. J., Snashall P. D. Histamine dose-response relationships in normal and asthmatic subjects. The importance of starting airway caliber. Am Rev Respir Dis. 1982 Nov;126(5):849–854. doi: 10.1164/arrd.1982.126.5.849. [DOI] [PubMed] [Google Scholar]
  8. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Protective effect of drugs on histamine-induced asthma. Thorax. 1977 Aug;32(4):429–437. doi: 10.1136/thx.32.4.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coupe M. O., Guly U., Brown E., Barnes P. J. Nebulised adrenaline in acute severe asthma: comparison with salbutamol. Eur J Respir Dis. 1987 Oct;71(4):227–232. [PubMed] [Google Scholar]
  10. Csete M. E., Chediak A. D., Abraham W. M., Wanner A. Airway blood flow modifies allergic airway smooth muscle contraction. Am Rev Respir Dis. 1991 Jul;144(1):59–63. doi: 10.1164/ajrccm/144.1.59. [DOI] [PubMed] [Google Scholar]
  11. Gilbert I. A., McFadden E. R., Jr Airway cooling and rewarming. The second reaction sequence in exercise-induced asthma. J Clin Invest. 1992 Sep;90(3):699–704. doi: 10.1172/JCI115940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gilbert I. A., Winslow C. J., Lenner K. A., Nelson J. A., McFadden E. R., Jr Vascular volume expansion and thermally induced asthma. Eur Respir J. 1993 Feb;6(2):189–197. [PubMed] [Google Scholar]
  13. Giner M. T., Nevot S., Sierra J. I., Plaza A., Coma G., Youssef W. Tratamiento de las crisis agudas de asma bronquial en niños con salbutamol subcutáneo como alternativa a la adrenalina: estudio comparativo. An Esp Pediatr. 1986 Sep;25(3):165–169. [PubMed] [Google Scholar]
  14. Goldie R. G., Paterson J. W., Spina D., Wale J. L. Classification of beta-adrenoceptors in human isolated bronchus. Br J Pharmacol. 1984 Apr;81(4):611–615. doi: 10.1111/j.1476-5381.1984.tb16125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grundström N., Andersson R. G., Wikberg J. E. Prejunctional alpha 2 adrenoceptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic neurotransmission. Life Sci. 1981 Jun 29;28(26):2981–2986. doi: 10.1016/0024-3205(81)90275-7. [DOI] [PubMed] [Google Scholar]
  16. Gustafsson B., Persson C. G. Effect of different bronchodilators on airway smooth muscle responsiveness to contractile agents. Thorax. 1991 May;46(5):360–365. doi: 10.1136/thx.46.5.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Higgins B. G., Powell R. M., Cooper S., Tattersfield A. E. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J. 1991 Apr;4(4):415–420. [PubMed] [Google Scholar]
  18. Kjellman B., Tollig H., Wettrell G. Inhalation of racemic epinephrine in children with asthma. Dose-response relation and comparison with salbutamol. Allergy. 1980 Oct;35(7):605–610. doi: 10.1111/j.1398-9995.1980.tb01811.x. [DOI] [PubMed] [Google Scholar]
  19. Knox A. J., Ajao P., Britton J. R., Tattersfield A. E. Effect of sodium-transport inhibitors on airway smooth muscle contractility in vitro. Clin Sci (Lond) 1990 Oct;79(4):315–323. doi: 10.1042/cs0790315. [DOI] [PubMed] [Google Scholar]
  20. Knox A. J., Campos-Gongora H., Wisniewski A., MacDonald I. A., Tattersfield A. E. Modification of bronchial reactivity by physiological concentrations of plasma epinephrine. J Appl Physiol (1985) 1992 Sep;73(3):1004–1007. doi: 10.1152/jappl.1992.73.3.1004. [DOI] [PubMed] [Google Scholar]
  21. Lockhart A., Dinh-Xuan A. T., Regnard J., Cabanes L., Matran R. Effect of airway blood flow on airflow. Am Rev Respir Dis. 1992 Nov;146(5 Pt 2):S19–S23. doi: 10.1164/ajrccm/146.5_Pt_2.S19. [DOI] [PubMed] [Google Scholar]
  22. Mathé A. A., Aström A., Persson N. A. Some bronchoconstricting and bronchodilating responses of human isolated bronchi: evidence for the existence of -adrenoceptors. J Pharm Pharmacol. 1971 Dec;23(12):905–910. doi: 10.1111/j.2042-7158.1971.tb09891.x. [DOI] [PubMed] [Google Scholar]
  23. McFadden E. R., Jr Hypothesis: exercise-induced asthma as a vascular phenomenon. Lancet. 1990 Apr 14;335(8694):880–883. doi: 10.1016/0140-6736(90)90478-n. [DOI] [PubMed] [Google Scholar]
  24. Moreno R. H., Hogg J. C., Paré P. D. Mechanics of airway narrowing. Am Rev Respir Dis. 1986 Jun;133(6):1171–1180. doi: 10.1164/arrd.1986.133.6.1171. [DOI] [PubMed] [Google Scholar]
  25. Olsson O. A., Swanberg E., Svedinger I., Waldeck B. Effects of beta-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle: in vitro and in vivo results compared. Acta Pharmacol Toxicol (Copenh) 1979 Apr;44(4):272–276. doi: 10.1111/j.1600-0773.1979.tb02329.x. [DOI] [PubMed] [Google Scholar]
  26. Phanichyakarn P. Comparison of subcutaneous injections of terbutaline, salbutamol and adrenaline in acute asthmatic attacks in children. J Med Assoc Thai. 1989 Dec;72(12):692–696. [PubMed] [Google Scholar]
  27. Phillips G. D., Finnerty J. P., Holgate S. T. Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma. J Allergy Clin Immunol. 1990 Apr;85(4):755–762. doi: 10.1016/0091-6749(90)90195-a. [DOI] [PubMed] [Google Scholar]
  28. Wagner E. M., Mitzner W. A. Bronchial circulatory reversal of methacholine-induced airway constriction. J Appl Physiol (1985) 1990 Oct;69(4):1220–1224. doi: 10.1152/jappl.1990.69.4.1220. [DOI] [PubMed] [Google Scholar]
  29. Warren J. B., Dalton N., Turner C., Clark T. J. Protective effect of circulating epinephrine within the physiologic range on the airway response to inhaled histamine in nonasthmatic subjects. J Allergy Clin Immunol. 1984 Nov;74(5):683–686. doi: 10.1016/0091-6749(84)90230-6. [DOI] [PubMed] [Google Scholar]
  30. Wong C. S., Pavord I. D., Williams J., Britton J. R., Tattersfield A. E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990 Dec 8;336(8728):1396–1399. doi: 10.1016/0140-6736(90)93099-b. [DOI] [PubMed] [Google Scholar]
  31. Yan K., Salome C., Woolcock A. J. Rapid method for measurement of bronchial responsiveness. Thorax. 1983 Oct;38(10):760–765. doi: 10.1136/thx.38.10.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zaagsma J., van der Heijden P. J., van der Schaar M. W., Bank C. M. Comparison of functional beta-adrenoceptor heterogeneity in central and peripheral airway smooth muscle of guinea pig and man. J Recept Res. 1983;3(1-2):89–106. doi: 10.3109/10799898309041925. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES